Turjeman et al., 2021 - Google Patents
Using the microbiome in clinical practiceTurjeman et al., 2021
View HTML- Document ID
- 1728517718135907561
- Author
- Turjeman S
- Koren O
- Publication year
- Publication venue
- Microbial Biotechnology
External Links
Snippet
Over the past 20 years, researchers have uncovered endless ways in which microbiota are associated with host health and behaviour. The microbiota throughout the body–gut, oral cavity, nasal cavity, skin, vagina–all function in a delicate balance aiding in digestion …
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3475—Computer-assisted prescription or delivery of diets, e.g. prescription filling or compliance checking
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Turjeman et al. | Using the microbiome in clinical practice | |
| Verhaar et al. | Gut microbiota composition is related to AD pathology | |
| Serrano-Villar et al. | Fecal microbiota transplantation in HIV: A pilot placebo-controlled study | |
| Chen et al. | A microbiota-directed food intervention for undernourished children | |
| Joos et al. | Examining the healthy human microbiome concept | |
| Kao et al. | Effect of oral capsule–vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial | |
| Costello et al. | Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial | |
| Wu et al. | Risk of inflammatory bowel disease in patients with rosacea: results from a nationwide cohort study in Taiwan | |
| Lappe et al. | Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial | |
| Browne et al. | Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia | |
| Braunschweig et al. | Intensive nutrition in acute lung injury: a clinical trial (INTACT) | |
| Reimers et al. | Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer | |
| Konturek et al. | Malnutrition in hospitals: it was, is now, and must not remain a problem! | |
| Bailey et al. | Association of antibiotics in infancy with early childhood obesity | |
| Omlin et al. | Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study | |
| Wutthi-In et al. | Gut microbiota profiles of treated metabolic syndrome patients and their relationship with metabolic health | |
| Guglielmi | Gut microbes join the fight against cancer | |
| Barthelemy et al. | Screening for malnutrition in lung cancer patients undergoing radiotherapy | |
| Jiménez et al. | Ligilactobacillus salivarius PS2 supplementation during pregnancy and lactation prevents mastitis: a randomised controlled trial | |
| Chen et al. | Aspirin vs placebo as adjuvant therapy for breast cancer: the alliance A011502 randomized trial | |
| Gilbert et al. | Clinical translation of microbiome research | |
| Nair et al. | Psoriasis bench to bedside: genetics meets immunology | |
| Thanush et al. | Current regulation and initial considerations for successful development and commercialization of microbiome therapies | |
| Dawson et al. | Early time-restricted eating improves markers of cardiometabolic health but has no impact on intestinal nutrient absorption in healthy adults | |
| Han et al. | Exploring the differences in the gut microbiome in atopic dermatitis according to the presence of gastrointestinal symptoms |